GLPG0187

DRUG2 trials

Sponsors

Galapagos NV

Conditions

HealthySolid Tumors

Phase 1

First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187

CompletedNCT00928343

Galapagos NVHealthy

Start: 2009-06-30End: 2009-12-31Updated: 2010-01-15

GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors

CompletedNCT01313598

Galapagos NVSolid Tumors

Start: 2011-03-31End: 2013-06-30Updated: 2013-06-11